Hormone Replacement Therapy

New Lower-Dose Estrogen Patch Approved for Menopause Symptoms

Published in Women's Health Weekly, December 16th, 1996

A just-approved, low-dose estrogen patch for preventing the hot flashes of menopause causes fewer side effects than other patches, the manufacture noted recently, and as a result, it may prevent women who cannot tolerate the side effects from abandoning estrogen replacement therapy.

The FemPatch, developed by the Parke-Davis subsidiary of Morris Plains-based Warner-Lambert Co., joins at least four estrogen patches already available commercially. The FemPatch has a lower dose of the drug estradiol than the other estrogen patches.

"There are several reasons women do not take or discontinue hormone replacement therapy," primarily the side effects,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-12-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry